Otsuka Rescues Fallen Unicorn Proteus Digital
Bankrupt US Venture To Support Digital Push
Japanese firm picks up struggling US venture for a fraction of its one-time value as it continues strategic push into the digital health space.
You may also be interested in...
Deal Snapshot: The firms are partnering on a digital therapeutic for schizophrenia in a deal potentially worth $500m.
Japanese major links with new partners in European consortium to progress first-in-class molecule for multiple hematological malignancies.
A resolution in a long-running patent dispute, expansion of coronavirus vaccine production, drug development trends over the past decade, hematological malignancies in a clinical trial, and the last instalment in the Scrip Asks series all feature in this week's podcast version of Scrip's Five Must-Know Things.